Cancer treatments ... antibodies against tumor antigens, checkpoint inhibitors that block tumors from accessing suppressive proteins on immune cells, and chimeric antigen receptor (CAR) T cells ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of stage 3 melanoma patients with positive tests experience a return of cancer.

The new test looks for a specific type ... up about half of all skin cancer sufferers -- determined that approximately 80% of those who had evidence of circulating tumor DNA, or ctDNA, in their ...

A prostate-specific antigen (PSA ... and Prevention (CDC), prostate cancer is the most common cancer among men in the United States, other than non-melanoma skin cancer. A PSA test alone doesn ...

Teddi Mellencamp’s life is hanging in the balance as she battles an aggressive form of Stage 4 skin cancer. The “Real ... for insight into the “black tumor” that sends about 8,000 ...

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been ... rendering it an ideal target for noninvasive and specific tumor detection. "So far, no IL13Rα2 ...

A multi-institutional team developed a chimeric antigen receptor ... drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer cells.

Evaxion Biotech A/S has announced promising new data on its personalized cancer vaccine, EVX-01, highlighting that 80% of the vaccine's targets elicited a tumor-specific immune response ...

Now, technological advances like rapid DNA sequencing, lymph node targeting, and AI-informed antigen ... cancer shows that Elicio’s vaccine induced 100-fold increases in tumor-specific T cells ...